BSE - Delayed Quote INR

Bliss GVS Pharma Limited (BLISSGVS.BO)

122.60 +5.85 (+5.01%)
At close: April 26 at 3:29 PM GMT+5:30
Key Events
Loading Chart for BLISSGVS.BO
DELL
  • Previous Close 116.75
  • Open 118.95
  • Bid 122.30 x --
  • Ask 123.25 x --
  • Day's Range 117.05 - 125.20
  • 52 Week Range 71.00 - 148.95
  • Volume 68,933
  • Avg. Volume 65,629
  • Market Cap (intraday) 12.835B
  • Beta (5Y Monthly) 0.99
  • PE Ratio (TTM) 14.77
  • EPS (TTM) 8.30
  • Earnings Date May 9, 2024 - May 13, 2024
  • Forward Dividend & Yield 0.50 (0.41%)
  • Ex-Dividend Date Jul 12, 2023
  • 1y Target Est 170.00

Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes. In addition, it offers therapeutic products consisting of anti-bacterial, anti-dandruff shampoo, amino acid preparation, iron tonic, antitussive, appetite stimulant, anti-allergic, body supplement, anti-biotic, anti-diabetic, anti-diarrheal, anti-emetic, anti-fungal, anti-haemorrhoidal, anti-helmintic, anti-infective, anti-inflammatory, anti-malarial, anti-microbial, anti-migraine, anti-oxidant, anti-protozoal, ear wax solvent, anti-pyretic, anti-septic, anti-spasmodic, anti-ulcer, and anti-ulcerant; and analgesic, oral rehydration, antacid, anxiolytic, appetizer, cough syrup, erectile dysfunction, haematinic, hand sanitizer, health supplement, insecticide, laryngitis, pharyngitis, laxative, lubricant, mosquito repellant, nasal decongestant, nutritional supplement, moisturizer, prickly heat powder, skin lightening lotion, vaginal contraceptive, vaginal hygiene, and vitamin supplements, as well as soaps. The company exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.

www.blissgvs.com

763

Full Time Employees

March 31

Fiscal Year Ends

Related News

Performance Overview: BLISSGVS.BO

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BLISSGVS.BO
1.61%
S&P BSE SENSEX
2.06%

1-Year Return

BLISSGVS.BO
59.78%
S&P BSE SENSEX
22.62%

3-Year Return

BLISSGVS.BO
20.73%
S&P BSE SENSEX
53.99%

5-Year Return

BLISSGVS.BO
27.84%
S&P BSE SENSEX
90.37%

Compare To: BLISSGVS.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BLISSGVS.BO

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    12.84B

  • Enterprise Value

    12.12B

  • Trailing P/E

    14.77

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.78

  • Price/Book (mrq)

    1.38

  • Enterprise Value/Revenue

    1.61

  • Enterprise Value/EBITDA

    8.22

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    11.62%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    7.57B

  • Net Income Avi to Common (ttm)

    879.46M

  • Diluted EPS (ttm)

    8.30

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.63B

  • Total Debt/Equity (mrq)

    10.34%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: BLISSGVS.BO

Analyst Price Targets

170.00
170.00 Average
122.60 Current
170.00 High
 

Fair Value

 

Company Insights: BLISSGVS.BO

People Also Watch